Monte Rosa Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Monte Rosa Therapeutics Inc
TickerGLUE
CIK #0001826457
CUSIP61225M102
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address645 Summer Street Suite 102, Boston, MA 02210
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Monte Rosa Therapeutics Inc 2021-03-24 95.0 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001826457] 10-K
[0001826457] 10-Q
[0001826457] 3
[0001826457] 4
[0001826457] 8-K
[0001826457] D
[0001826457] SC 13D
[0001826457] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
TCG Crossover GP II LLC Monte Rosa Therapeutics Inc [2025-10-17] 0.0
Dimension Capital I LP Monte Rosa Therapeutics Inc [2025-10-03] 0.0
Suvretta Capital Management LLC Monte Rosa Therapeutics Inc [2025-04-16] 0.0
BlackRock Inc Monte Rosa Therapeutics Inc [2025-02-04] 0.0
Biotechnology Value Fund L P Monte Rosa Therapeutics Inc [2025-01-31] 0.0
Vanguard Group Inc Monte Rosa Therapeutics Inc [2025-01-30] 0.0
Baker Bros Advisors LP Monte Rosa Therapeutics Inc [2024-02-14] 9.8
BlackRock Inc Monte Rosa Therapeutics Inc [2023-02-03] 7.4
Avoro Capital Advisors LLC Monte Rosa Therapeutics Inc [2022-02-11] 7.1
Price T Rowe Associates Inc /MD/ Monte Rosa Therapeutics Inc [2022-02-10] 8.9
BlackRock Inc Monte Rosa Therapeutics Inc [2022-02-04] 5.1
FMR LLC Monte Rosa Therapeutics Inc [2021-08-10] 0.0
New Enterprise Associates 17 LP Monte Rosa Therapeutics Inc [2021-07-12] 17.3
Versant Venture Capital VI LP Monte Rosa Therapeutics Inc [2021-07-08] 11.0
Cormorant Asset Management LP Monte Rosa Therapeutics Inc [2021-07-08] 2.07
Form 3/4/5 Filer 2011 - 2026
Monte Rosa Therapeutics Inc
Townson Sharon
Behbahani Ali
Janku Filip
Manning Anthony M
Champoux Jennifer
Hughes Eric A
Skvarka Jan
Siu Christine
Schiff Andrew N
Blackwell Kimberly
Warmuth Markus
Nickson Philip
Bowen Matthew
Dunn Edmund
Leo Chandra P
Versant Vantage I LP
Versant Vantage I GP-GP LLC
Versant Ventures VI GP LP
Versant Vantage I GP LP
Versant Ventures VI GP-GP LLC
Versant Venture Capital VI LP
Jones Jullian G
Wallace Owen B
Mayweg Alexander
Tamboli Ajim
Castle John C
Cormorant Private Healthcare Fund II LP
Cormorant Global Healthcare Master Fund LP
Chen Bihua
Cormorant Private Healthcare Fund III LP
Cormorant Asset Management LP
Bolzon Bradley J PhD
NEA 17 GP LLC
New Enterprise Associates 17 LP
NEA Partners 17 LP
Baskett Forest
Chang Carmen
Florence Anthony A Jr
Landsman Liza
Makhzoumi Mohamad
Makower Joshua
Mathers Edward T
Sandell Scott D
Sonsini Peter W
Walker Paul Edward
Yang Rick
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Dunn Edmund
Common Stock
2026-03-04 Sell 139 $17.96 2,496
Dunn Edmund
Stock Option (Right to Buy) · derivative
2026-03-02 Option exercise 536 $0.00
Dunn Edmund
Common Stock
2026-03-02 Sell 536 $17.50 9,380
Warmuth Markus
Common Stock
2026-03-02 Sell 5,466 $17.92 97,951
Dunn Edmund
Common Stock
2026-03-02 Option exercise 536 $13.41 7,188
Dunn Edmund
Common Stock
2026-02-27 Option exercise 25,164 $13.41 337,449
Dunn Edmund
Common Stock
2026-02-27 Sell 25,164 $18.10 455,468
Dunn Edmund
Stock Option (Right to Buy) · derivative
2026-02-27 Option exercise 25,164 $0.00
Janku Filip
Common Stock
2026-02-23 Sell 9,189 $19.50 179,186
Warmuth Markus
Common Stock
2026-01-07 Sell 3,707 $23.24 86,151
Warmuth Markus
Common Stock
2026-01-07 Sell 309 $24.57 7,592
Warmuth Markus
Common Stock
2026-01-07 Sell 1,450 $23.88 34,626
Townson Sharon
Common Stock
2026-01-05 Sell 3,155 $15.17 47,861
Dunn Edmund
Common Stock
2026-01-05 Sell 1,039 $15.17 15,762
Warmuth Markus
Common Stock
2026-01-05 Sell 10,135 $15.17 153,748
Nickson Philip
Common Stock
2026-01-05 Sell 3,155 $15.17 47,861
Janku Filip
Common Stock
2026-01-05 Sell 3,155 $15.17 47,861
Champoux Jennifer
Common Stock
2026-01-05 Sell 2,629 $15.17 39,882
Townson Sharon
Stock Option (Right to Buy) · derivative
2026-01-02 Grant 158,000 $0.00
Nickson Philip
Common Stock
2026-01-02 Grant 28,000
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 191 80,118,205
2025-12-31 161 59,008,267
2025-09-30 129 55,187,266
2025-06-30 116 56,447,926
2025-03-31 108 53,077,305
2024-12-31 107 54,266,443
2024-09-30 83 43,386,899
2024-06-30 76 40,026,225
2024-03-31 70 35,061,345
2023-12-31 73 35,944,202
2023-09-30 74 38,602,393
2023-06-30 70 35,254,516
Form 13F Holdings
Firm Period DFND Voting Shares
Wealth Enhancement Advisory Services LLC [2026-06-30] SOLE 1,323 25,921
Y-Intercept Hong Kong Ltd [2026-06-30] SOLE 25,149 25,149
PSP Research LLC [2026-06-30] SOLE 0 23,000
Mayflower Financial Advisors LLC [2026-06-30] SOLE 0 10,000
Gamma Investing LLC [2026-06-30] DFND 2,114 2,114
IFP Advisors LLC [2026-06-30] SOLE 1,178 1,178
Farther Finance Advisors LLC [2026-06-30] SOLE 0 315
Fortitude Family Office LLC [2026-06-30] SOLE 263 263
True Wealth Design LLC [2026-06-30] SOLE 0 84
Dogwood Wealth Management LLC [2026-06-30] SOLE 54 54
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com